IntegraGen is a leader in genome analysis and the development and commercialization of molecular diagnostic tests for oncology.
Genomic Services
miRpredX 31-3p
Investors
Latest news // Archive
-
News
IntegraGen to attend ASCO 2018 – June 1st to 5th in Chicago
-
Press releases
IntegraGen Achieves ISO 13485:2016 Certification for the Design, Manufacturing and Distribution of In Vitro Diagnostic Kits
-
Press releases
IntegraGen Reports 2017 Annual Results: Continued Strength in Clinical Genomic Services and Improved Net Income